https://ml-eu.globenewswire.com/Resource/Download/f1aaffc3-afa9-43e4-8466-45fb87e... | ObsEva Announces Corporate Updates | https://www.globenewswire.com/news-release/2022/07/27/2486494/0/en/ObsEva-Announc... | July 27, 2022 00:55 ET | |
Source:
ObsEva SA | ObsEva Announces Corporate Updates | https://www.globenewswire.com/news-release/2022/07/27/2486494/0/en/ObsEva-Announc... | Ad hoc announcement pursuant to Art. 53 LR of the SIX Swiss Exchange GENEVA, Swit... | ObsEva SA | July 27, 2022 00:55 ET | | https://www.globenewswire.com/search/industry/biotechnology,pharmaceuticals%25252... | https://www.globenewswire.com/search/industry/biotechnology,pharmaceuticals%25252... | 2022-07-27 07:12:49 UTC | 2022-07-27 07:12:49 UTC | 2022-07-27 07:12:49 UTC |
https://ml-eu.globenewswire.com/Resource/Download/f1aaffc3-afa9-43e4-8466-45fb87e... | ObsEva Announces Corporate Updates | https://www.globenewswire.com/news-release/2022/07/27/2486501/0/en/ObsEva-Announc... | July 27, 2022 01:00 ET | |
Source:
ObsEva SA | ObsEva Announces Corporate Updates | https://www.globenewswire.com/news-release/2022/07/27/2486501/0/en/ObsEva-Announc... | Ad hoc announcement pursuant to Art. 53 LR of the SIX Swiss Exchange GENEVA, Sw... | ObsEva SA | July 27, 2022 01:00 ET | | https://www.globenewswire.com/search/industry/biotechnology,pharmaceuticals%25252... | https://www.globenewswire.com/search/industry/biotechnology,pharmaceuticals%25252... | 2022-07-27 07:12:49 UTC | 2022-07-27 07:12:49 UTC | 2022-07-27 07:12:49 UTC |
https://ml.globenewswire.com/Resource/Download/1a48a25b-b654-4d62-adb3-d1a7763462... | Clover Health Announces Inducement Grant under Nasdaq Listing Rule 5635(c)(4) | https://www.globenewswire.com/news-release/2022/07/26/2486416/0/en/Clover-Health-... | July 26, 2022 16:43 ET | |
Source:
Clover Health Investments, Corp. | Clover Health Announces Inducement Grant under Nasdaq Listing Rule 5635(c)(4) | https://www.globenewswire.com/news-release/2022/07/26/2486416/0/en/Clover-Health-... | FRANKLIN, Tenn., July 26, 2022 (GLOBE NEWSWIRE) -- On July 25, 2022, Scott J. Lef... | Clover Health Investments, Corp. | July 26, 2022 16:43 ET | | https://www.globenewswire.com/search/industry/biotechnology,pharmaceuticals%25252... | https://www.globenewswire.com/search/industry/biotechnology,pharmaceuticals%25252... | 2022-07-27 07:12:49 UTC | 2022-07-27 07:12:49 UTC | 2022-07-27 07:12:49 UTC |
https://ml.globenewswire.com/Resource/Download/53dd23f0-4b5b-4b6b-9dfa-22b5db4c92... | Acumen Pharmaceuticals to Participate in Upcoming Investor and Scientific Confere... | https://www.globenewswire.com/news-release/2022/07/26/2486388/0/en/Acumen-Pharmac... | July 26, 2022 16:15 ET | |
Source:
Acumen Pharmaceuticals, Inc. | Acumen Pharmaceuticals to Participate in Upcoming Investor and Scientific Confere... | https://www.globenewswire.com/news-release/2022/07/26/2486388/0/en/Acumen-Pharmac... | CHARLOTTESVILLE, Va. and CARMEL, Ind., July 26, 2022 (GLOBE NEWSWIRE) -- Acumen P... | Acumen Pharmaceuticals, Inc. | July 26, 2022 16:15 ET | | https://www.globenewswire.com/search/industry/biotechnology,pharmaceuticals%25252... | https://www.globenewswire.com/search/industry/biotechnology,pharmaceuticals%25252... | 2022-07-27 07:12:49 UTC | 2022-07-27 07:12:49 UTC | 2022-07-27 07:12:49 UTC |
https://ml.globenewswire.com/Resource/Download/707438e3-1bae-4793-ad4e-d69afa9445... | Harvard Bioscience Schedules Second Quarter 2022 Earnings Conference Call for Aug... | https://www.globenewswire.com/news-release/2022/07/26/2486418/11635/en/Harvard-Bi... | July 26, 2022 16:50 ET | |
Source:
Harvard Bioscience, Inc. | Harvard Bioscience Schedules Second Quarter 2022 Earnings Conference Call for Aug... | https://www.globenewswire.com/news-release/2022/07/26/2486418/11635/en/Harvard-Bi... | HOLLISTON, Mass., July 26, 2022 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nas... | Harvard Bioscience, Inc. | July 26, 2022 16:50 ET | | https://www.globenewswire.com/search/industry/biotechnology,pharmaceuticals%25252... | https://www.globenewswire.com/search/industry/biotechnology,pharmaceuticals%25252... | 2022-07-27 07:12:49 UTC | 2022-07-27 07:12:49 UTC | 2022-07-27 07:12:49 UTC |
https://ml.globenewswire.com/Resource/Download/8eef1fda-a775-421e-9f49-804f467ece... | Albireo Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) | https://www.globenewswire.com/news-release/2022/07/26/2486403/0/en/Albireo-Report... | July 26, 2022 16:30 ET | |
Source:
Albireo Pharma, Inc. | Albireo Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) | https://www.globenewswire.com/news-release/2022/07/26/2486403/0/en/Albireo-Report... | BOSTON, July 26, 2022 (GLOBE NEWSWIRE) -- Albireo Pharma, Inc. (Nasdaq: ALBO), a ... | Albireo Pharma, Inc. | July 26, 2022 16:30 ET | | https://www.globenewswire.com/search/industry/biotechnology,pharmaceuticals%25252... | https://www.globenewswire.com/search/industry/biotechnology,pharmaceuticals%25252... | 2022-07-27 07:12:49 UTC | 2022-07-27 07:12:49 UTC | 2022-07-27 07:12:49 UTC |
https://ml.globenewswire.com/Resource/Download/d0d4a766-5115-448d-ba8a-d522100949... | Bluejay Diagnostics, Inc. Reports Second Quarter 2022 Financial Results | https://www.globenewswire.com/news-release/2022/07/26/2486401/0/en/Bluejay-Diagno... | July 26, 2022 16:30 ET | |
Source:
Bluejay Diagnostics, Inc. | Bluejay Diagnostics, Inc. Reports Second Quarter 2022 Financial Results | https://www.globenewswire.com/news-release/2022/07/26/2486401/0/en/Bluejay-Diagno... | ACTON, Mass., July 26, 2022 (GLOBE NEWSWIRE) -- Bluejay Diagnostics, Inc. (NASDAQ... | Bluejay Diagnostics, Inc. | July 26, 2022 16:30 ET | | https://www.globenewswire.com/search/industry/biotechnology,pharmaceuticals%25252... | https://www.globenewswire.com/search/industry/biotechnology,pharmaceuticals%25252... | 2022-07-27 07:12:49 UTC | 2022-07-27 07:12:49 UTC | 2022-07-27 07:12:49 UTC |
https://ml.globenewswire.com/Resource/Download/f056feb2-6bc8-4b87-9aa3-e40b6b1d6a... | AISA Pharma Announces Positive Data Safety Monitoring Board Review of First Phase... | https://www.globenewswire.com/news-release/2022/07/26/2486441/0/en/AISA-Pharma-An... | July 26, 2022 17:50 ET | |
Source:
Aisa Pharma, Inc. | AISA Pharma Announces Positive Data Safety Monitoring Board Review of First Phase... | https://www.globenewswire.com/news-release/2022/07/26/2486441/0/en/AISA-Pharma-An... | BOSTON, July 26, 2022 (GLOBE NEWSWIRE) -- Aisa Pharma, Inc. a privately-funded, c... | Aisa Pharma, Inc. | July 26, 2022 17:50 ET | | https://www.globenewswire.com/search/industry/biotechnology,pharmaceuticals%25252... | https://www.globenewswire.com/search/industry/biotechnology,pharmaceuticals%25252... | 2022-07-27 07:12:49 UTC | 2022-07-27 07:12:49 UTC | 2022-07-27 07:12:49 UTC |
| Sage Institute awarded $250,000 to support clinical and training programs | https://www.globenewswire.com/news-release/2022/07/26/2486409/0/en/Sage-Institute... | July 26, 2022 16:31 ET | |
Source:
Sage Institute for Psychedelic Therapy | Sage Institute awarded $250,000 to support clinical and training programs | https://www.globenewswire.com/news-release/2022/07/26/2486409/0/en/Sage-Institute... | OAKLAND, Calif., July 26, 2022 (GLOBE NEWSWIRE) -- Sage Institute for Psychedelic... | Sage Institute for Psychedelic Therapy | July 26, 2022 16:31 ET | | https://www.globenewswire.com/search/industry/biotechnology,pharmaceuticals%25252... | https://www.globenewswire.com/search/industry/biotechnology,pharmaceuticals%25252... | 2022-07-27 07:12:49 UTC | 2022-07-27 07:12:49 UTC | 2022-07-27 07:12:49 UTC |
https://ml.globenewswire.com/Resource/Download/f221f83c-1e1f-4b0b-9242-6842ca06e8... | Summit Therapeutics Appoints Dr. Maky Zanganeh as Co-CEO & President | https://www.globenewswire.com/news-release/2022/07/26/2486391/0/en/Summit-Therape... | July 26, 2022 16:15 ET | |
Source:
Summit Therapeutics Inc. | Summit Therapeutics Appoints Dr. Maky Zanganeh as Co-CEO & President | https://www.globenewswire.com/news-release/2022/07/26/2486391/0/en/Summit-Therape... | Menlo Park, California, July 26, 2022 (GLOBE NEWSWIRE) -- Summit Therapeutics Inc... | Summit Therapeutics Inc. | July 26, 2022 16:15 ET | | https://www.globenewswire.com/search/industry/biotechnology,pharmaceuticals%25252... | https://www.globenewswire.com/search/industry/biotechnology,pharmaceuticals%25252... | 2022-07-27 07:12:49 UTC | 2022-07-27 07:12:49 UTC | 2022-07-27 07:12:49 UTC |